B O O K - American College of Rheumatology

ACR Poster Session A
University of Melbourne, 5 John Hunter Hospital, Newcastle,
Australia, 6 Menzies Research Institute, University of Tasmania,
Hobart, Australia, 7 Monash Medical Centre, Melbourne,
Australia, 8 Queen Elizabeth Hospital, Adelaide, Australia,
9
Royal Adelaide Hospital, Adelaide, Australia, 10 Royal North
Shore Hospital, Sydney, Australia, 11 Royal Perth Hospital, Perth,
Australia, 12 Royal Prince Alfred Hospital, Sydney, Australia, 13 St
George Hospital, Sydney, Australia, 14 St Vincent’s Hospital,
Melbourne, Australia, 15 Sunshine Coast Rheumatology,
Australia.
585. Pulmonary Artery Diameter Is Associated with Pulmonary
Hypertension in Patients with Systemic Sclerosis (SSc).
Elena Schiopu 4 , Ann J. Impens 4 , Barry H. Gross 3 , Fazleomar
Mahmood 4 , James R. Seibold 1 and Kristine Phillips 2 , 1 University
of Connecticut Health Center, Farmington, CT, 2 University of
Michigan, Ann Arbor, MI, 3 University of Michigan, Department
of Radiology, Ann Arbor, MI, 4 University of Michigan,
Scleroderma Program, Ann Arbor, MI.
586. Pulmonary Hypertension Assessment and Recognition of
Outcomes in Scleroderma (PHAROS): Comparison of Outcomes
in Subtypes of Pulmonary Hypertension. Robyn T. Domsic 6 ,
Lorinda Chung 3 , Mardi Gomnberg-Maitland 4 , Jessica K. Gordon 2 ,
Barbara M. Segal 5 , Virginia D. Steen 1 and PHAROS Investigators,
1
Gerogetown University Medical Center, Washington, DC,
2
Hospital for Special Surgery, New York, NY, 3 Stanford University
Medical Center, Palo Alto, CA, 4 University of Chicago Medical
Center, Chicago, IL, 5 University of Minnesota, Minneapolis, MN,
6
University of Pittsburgh, Pittsburgh, PA.
587. Pulmonary Hypertension by Age of Scleroderma Onset and
Subtype. Rebecca L. Manno 2 , Fredrick M. Wigley 1 and Laura K.
Hummers 2 , 1 Johns Hopkins University, Baltimore, MD, 2 Johns
Hopkins University, Baltimore, MD.
588. Reproducibility of Semi-Automated Quantitative Nailfold
Capillaroscopy Measurements in Patients with Systemic
Sclerosis. Andrea K. Murray 4 , Tonia L. Moore 4 , Andy Vail 1 ,
Joanne Manning 2 and Ariane L. Herrick 3 , 1 Rheumatology
Directorate, HealthMethodology Research Group, Manchester
Academic Health ScienceCentre, The University of
Manchester, Salford Royal Hospital, Salford, UK, 2 Salford Royal
NHSFoundation Trust, Salford, 3 The University of Manchester,
Manchester Academic Health Science Centre, Manchester,
Salford Royal Hospital, Salford, Greater Manchester, United
Kingdom, 4 The University of Manchester, Manchester Academic
Health Science Centre, Manchester, Salford Royal Hospital, UK.
589. Risk Associated with African American Race in Relation
to Prevalence of Cardinal Organ System Manifestations in
Scleroderma. Elizabeth N. Le 3 , Rebecca L. Manno 3 , Laura K.
Hummers 3 , Fredrick M. Wigley 2 and Allan C. Gelber 1 , 1 Baltimore,
MD, 2 Johns Hopkins University, Baltimore, MD, 3 Johns Hopkins
University, Baltimore, MD.
590. Role of N-Terminal Pro-BNP in Detecting Clinically-Significant
Cardiac Involvement in Systemic Sclerosis Patients. Cecilia
Chighizola 3 , Benjamin Schreiber 2 , Pier Luigi Meroni 3 , Gerry
Coghlan 1 , Christopher P. Denton 4 and Voon Ong 1 , 1 Center for
Rheumatology and Connective Tissue Diseases, UCL Medical
School, Royal Free Hospital, London, United Kingdom, 2 Center
for Rheumatology and Connective Tissue Diseases, UCL Medical
School, Royal Free Hospital, London, 3 Rheumatology Division,
Department of Internal Medicine, Istituto G. Pini, University
of Milan, Milan, Italy, 4 Royal Free Hospital, London, United
Kingdom.
591. Scleroderma Autoantibodies and Disease Subtype Predict
Pulmonary Hypertension Classification in the PHAROS
Registry. Monique E. Hinchcliff 5 , Aryeh Fischer 4 , Nadera Sweiss 6 ,
Maureen Mayes 7 , Marcy Bolster 3 , Virginia Steen 1 and PHAROS
Investigators 2 , 1 Georgetown University, 2 Gerogetwon University,
3
Medical University of South Carolina, 4 National Jewish Health,
5
Northwestern University, 6 University of Chicago, 7 University of
Texas-Houston Medical School.
592. Scleroderma Lung Disease: Effect of Co-Existent Pulmonary
Hypertension on Progression of Interstitial Lung Disease.
Anupama Shahane, Joseph Parambil, Meng Xu and Soumya
Chatterjee, Cleveland Clinic.
593. Sildenafil Increases Vasodilation in Systemic Sclerosis: An
Interim Analysis from a Single Centre Pilot Study. Silvia
Bellando-Randone, Irene Miniati, Serena Guiducci, Maria Letizia
Conforti, Jelena Blagojevic, Ginevra Fiori, Francesca Bartoli,
Francesca Nacci and Marco Matucci-Cerinic, Department of
Biomedicine Section of Rheumatology University of Florence,
Italy.
594. Subclinical Atherosclerosis Is Increased in Systemic Sclerosis
— A Case-Control Study. Karen M. Au 1 , Maureen A. McMahon 1 ,
Daniel E. Furst 3 , Bevra H. Hahn 4 , Nagesh Ragavendra 1 , Amber
Bechtel 1 , Lori Sahakian 1 and Dinesh Khanna 2 , 1 UCLA School of
Medicine, Los Angeles, CA, 2 University of California Los Angeles,
Los Angeles, CA, 3 University of California Los Angeles Medical
School, Los Angeles, CA, 4 University of California Los Angeles
School of Medicine, Los Angeles, CA.
595. Symptom Burden, Quality of Life and Attitudes toward
Palliative Care in Patients with Pulmonary Hypertension with
and without Systemic Sclerosis. Nicole M. Orzechowski 1 , Keith
M. Swetz 2 , Tait D. Shanafelt 3 , Jeff A. Sloan 3 , Paul J. Novotny 3 ,
Robert P. Frantz 3 and Michael D. McGoon 3 , 1 Dartmouth
Hitchcock Med Center, Lebanon, NH, 2 Mayo Clinic, Rochester,
MN, 3 Mayo Clinic.
596. The Degree of Skin Involvement Predicts Distinct Interstitial
Lung Disease Outcomes in Systemic Sclerosis. Tricia R. Cottrell,
Fredrick Wigley, Robert Wise and Francesco Boin, Johns Hopkins
University, Baltimore, MD.
597. The Effect of Gastric Acid Suppression with Esomeprazole
on Treprostinil Diethanolamine Pharmacokinetics in Healthy
Volunteers. Kristan Rollins 2 , Susan Walker 2 , Jennifer Kates 2 ,
Kevin Laliberte 2 and Allison Lim 1 , 1 United Therapetutics,
Research Triangle Park, NC, 2 United Therapeutics.
598. The Pulmonary Arterial Hypertension Quality Enhancement
Research Initiative (PAH-QuERI): Comparing Baseline
Characteristics, Management and Survival in Patients with
Idiopathic PAH (IPAH) to Patients with Systemic Sclerosis
Related PAH (SSc-PAH). Philip J. Clements 2 , Amparo Casanova 1 ,
Tan Mary 1 , Channick Richard 4 , Valerie McLaughlin 6 , Ron Oudiz 2 ,
Lew Rubin 5 , Tapson Victor 3 and Langer Anatoly 1 , 1 Canadian
Heart Research Center, 2 David Geffen School of Medicine
at UCLA, 3 Duke University Medical Center, Durham, NC,
4
Massachusetts General Hospital, 5 University of California at San
Diego, 6 University of Michigan Health System.
188
2010 Program Book